Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Inflammopharmacology ; 28(4): 1091-1119, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32232632

ABSTRACT

Marine sponges are prolific producers of an array of diverse chemical structures containing compounds with multiple biological activities. In this study, whole methanol extracts and fractionated compounds from three marine sponges namely Xestospongia carbonaria, Sarcotragus foetidus and Spongia obscura were thoroughly investigated for their antibacterial, antifungal, antioxidant and anti-inflammatory activities. Methanol extracts and fractionated compounds were characterised using high performance liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry. Extracts were checked for cytotoxicity in RAW macrophages by MTT assay, before using them for the treatment study. Enzyme linked immunosorbent assay kits were used to check the effects on inflammatory mediator's levels (PGE2, COX-2, IL-6, IL-1ß, TNF-α) in vitro. The results demonstrated good anti-inflammatory activity of all the three marine sponges; X. carbonaria, S. foetidus and S. obscura suppressed the levels of anti-inflammatory cytokines in vitro. Reverse transcriptase-polymerase chain reaction confirmed the inhibition of IL-1ß and IL-6 genes expression by the isolates of X. carbonaria and S. foetidus, while reducing cytokine levels in lipopolysaccharide-induced inflammation in vitro as well as in carrageenan-induced inflammation in rats. Two semi pure compounds isolated from X. carbonaria and S. foetidus also confirmed suppression of IL-1ß and IL-6 genes expression in RAW macrophages.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Edema/drug therapy , Interleukin-1beta/metabolism , Interleukin-6/metabolism , Macrophages/drug effects , Porifera/chemistry , Xestospongia/chemistry , Animals , Carrageenan/pharmacology , Cell Line , Cyclooxygenase 2/metabolism , Cytokines/metabolism , Dinoprostone/metabolism , Disease Models, Animal , Edema/chemically induced , Edema/metabolism , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/metabolism , Inflammation Mediators/pharmacology , Lipopolysaccharides/pharmacology , Macrophages/metabolism , Male , Mice , Nitric Oxide/metabolism , RAW 264.7 Cells , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...